SUMO playing tag with ubiquitin

Trends in Biochemical Sciences

Volumn 37, Issue 1, 2012, Pages 23-31

  Praefcke, Gerrit J K ^a   Hofmann, Kay ^b   Dohmen, R Jürgen ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b MILTENYI BIOTEC GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 2ALPHA; REACTIVE OXYGEN METABOLITE; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN; SUMO PROTEIN; UBIQUITIN;

CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL GROWTH; CELL VIABILITY; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; HYDROPHOBICITY; MEIOSIS; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SACCHAROMYCES CEREVISIAE; SCHIZOSACCHAROMYCES POMBE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SUMOYLATION; TRANSCRIPTION REGULATION; UBIQUITINATION;

ANIMALS; DNA DAMAGE; ENZYMES; HUMANS; SUMO-1 PROTEIN; UBIQUITINS;

EID: 84855590990     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2011.09.002     Document Type: Review

References (85)

1. Kerscher O., et al. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell. Dev. Biol. 2006, 22:159-180.
2. Komander D. The emerging complexity of protein ubiquitination. Biochem. Soc. Trans. 2009, 37:937-953.
3. Johnson E.S. Protein modification by SUMO. Annu. Rev. Biochem. 2004, 73:355-382.
4. Geiss-Friedlander R., Melchior F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 2007, 8:947-956.
5. Ulrich H.D. The SUMO system: an overview. Methods Mol. Biol. 2009, 497:3-16.
6. Tatham M.H., et al. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 2001, 276:35368-35374.
7. Bylebyl G.R., et al. The SUMO isopeptidase Ulp2 prevents accumulation of SUMO chains in yeast. J. Biol. Chem. 2003, 278:44112-44120.
8. Xu P., et al. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 2009, 137:133-145.
9. Matic I., et al. In vivo identification of human SUMO polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Mol. Cell. Proteomics 2007, 7:132-144.
10. Perry J.J., et al. A SIM-ultaneous role for SUMO and ubiquitin. Trends Biochem. Sci. 2008, 33:201-208.
11. Miteva M., et al. Sumoylation as a signal for polyubiquitylation and proteasomal degradation. Subcell. Biochem. 2010, 54:195-214.
12. Desterro J.M., et al. SUMO-1 modification of IκBα inhibits NF-κB activation. Mol. Cell 1998, 2:233-239.
13. Hoege C., et al. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 2002, 419:135-141.
14. Huang T.T., et al. Sequential modification of NEMO/IKKγ by SUMO-1 and ubiquitin mediates NF-κB activation by genotoxic stress. Cell 2003, 115:565-576.
15. Moldovan G.L., et al. PCNA, the maestro of the replication fork. Cell 2007, 129:665-679.
16. Branzei D., et al. SUMOylation regulates Rad18-mediated template switch. Nature 2008, 456:915-920.
17. Pfander B., et al. SUMO-modified PCNA recruits Srs2 to prevent recombination during S phase. Nature 2005, 436:428-433.
18. Papouli E., et al. Crosstalk between SUMO and ubiquitin on PCNA is mediated by recruitment of the helicase Srs2p. Mol. Cell 2005, 19:123-133.
19. Uzunova K., et al. Ubiquitin-dependent proteolytic control of SUMO conjugates. J. Biol. Chem. 2007, 282:34167-34175.
20. Prudden J., et al. SUMO-targeted ubiquitin ligases in genome stability. EMBO J. 2007, 26:4089-4101.
21. Sun H., et al. Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins. EMBO J. 2007, 26:4102-4112.
22. Xie Y., et al. The yeast HEX3-SLX8 heterodimer is a ubiquitin ligase stimulated by substrate sumoylation. J. Biol. Chem. 2007, 282:34176-34184.
23. Tatham M.H., et al. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat. Cell Biol. 2008, 10:538-546.
24. Lallemand-Breitenbach V., et al. Arsenic degrades PML or PML-RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat. Cell Biol. 2008, 10:547-555.
25. Weisshaar S.R., et al. Arsenic trioxide stimulates SUMO-2/3 modification leading to RNF4-dependent proteolytic targeting of PML. FEBS Lett. 2008, 582:3174-3178.
26. Mullen J.R., et al. Requirement for three novel protein complexes in the absence of the Sgs1 DNA helicase in Saccharomyces cerevisiae. Genetics 2001, 157:103-118.
27. Nagai S., et al. Functional targeting of DNA damage to a nuclear pore-associated SUMO-dependent ubiquitin ligase. Science 2008, 322:597-602.
28. Wang Z., Prelich G. Quality control of a transcriptional regulator by SUMO-targeted degradation. Mol. Cell. Biol. 2009, 29:1694-1706.
29. Tatham M.H., et al. Comparative proteomic analysis identifies a role for SUMO in protein quality control. Sci. Signal. 2011, 4:rs4.
30. Heideker J., et al. Genome stability roles of SUMO-targeted ubiquitin ligases. DNA Repair 2009, 8:517-524.
31. Sekiyama N., et al. Structural basis for regulation of poly-SUMO chain by a SUMO-like domain of Nip45. Proteins 2010, 78:1491-1502.
32. Heideker J., et al. SUMO-targeted ubiquitin ligase, Rad60, and Nse2 SUMO ligase suppress spontaneous Top1-mediated DNA damage and genome instability. PLoS Genet. 2011, 7:e1001320.
33. Liew C.W., et al. RING domain dimerization is essential for RNF4 function. Biochem. J. 2010, 431:23-29.
34. Plechanovova A., et al. Mechanism of ubiquitylation by dimeric RING ligase RNF4. Nat. Struct. Mol. Biol. 2011, 18:1052-1059.
35. Mukhopadhyay D., et al. The SUMO protease SENP6 is essential for inner kinetochore assembly. J. Cell Biol. 2010, 188:681-692.
36. van Hagen M., et al. RNF4 and VHL regulate the proteasomal degradation of SUMO-conjugated hypoxia-inducible factor-2α. Nucleic Acids Res. 2010, 38:1922-1931.
37. Bruderer R., et al. Purification and identification of endogenous polySUMO conjugates. EMBO Rep. 2011, 12:142-148.
38. Golebiowski F., et al. System-wide changes to SUMO modifications in response to heat shock. Sci. Signal. 2009, 2:ra24.
39. Hu X.V., et al. Identification of RING finger protein 4 (RNF4) as a modulator of DNA demethylation through a functional genomics screen. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:15087-15092.
40. Abed M., et al. Degringolade, a SUMO-targeted ubiquitin ligase, inhibits Hairy/Groucho-mediated repression. EMBO J. 2011, 30:1289-1301.
41. Barry K.C., et al. The Drosophila STUbL protein Degringolade limits HES functions during embryogenesis. Development 2011, 138:1759-1769.
42. Xie Y., et al. SUMO-independent in vivo activity of a SUMO-targeted ubiquitin ligase toward a short-lived transcription factor. Genes Dev. 2010, 24:893-903.
43. Lee F.S., Percy M.J. The HIF pathway and erythrocytosis. Annu. Rev. Pathol. 2011, 6:165-192.
44. Cheng J., et al. SUMO-specific protease 1 is essential for stabilization of HIF1α during hypoxia. Cell 2007, 131:584-595.
45. Berta M.A., et al. SUMOylation of hypoxia-inducible factor-1α reduces its transcriptional activity. Biochem. Biophys. Res. Commun. 2007, 360:646-652.
46. Kang X., et al. PIASy stimulates HIF1α SUMOylation and negatively regulates HIF1α activity in response to hypoxia. Oncogene 2010, 29:5568-5578.
47. Carbia-Nagashima A., et al. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1α during hypoxia. Cell 2007, 131:309-323.
48. Cai Q., Robertson E.S. Ubiquitin/SUMO modification regulates VHL protein stability and nucleocytoplasmic localization. PLoS ONE 2010, 5:e12636.
49. Ulrich H.D., Walden H. Ubiquitin signalling in DNA replication and repair. Nat. Rev. Mol. Cell Biol. 2010, 11:479-489.
50. Galanty Y., et al. Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature 2009, 462:935-939.
51. Morris J.R., et al. The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature 2009, 462:886-890.
52. Cook C.E., et al. The SUMO-targeted ubiquitin ligase subunit Slx5 resides in nuclear foci and at sites of DNA breaks. Cell Cycle 2009, 8:1080-1089.
53. Rajendra R., et al. Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53. J. Biol. Chem. 2004, 279:36440-36444.
54. Weger S., et al. Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo. FEBS Lett. 2005, 579:5007-5012.
55. Yang X., et al. Plk1-mediated phosphorylation of Topors regulates p53 stability. J. Biol. Chem. 2009, 284:18588-18592.
56. Yang X., et al. Plk1 phosphorylation of Topors is involved in its degradation. Mol. Biol. Rep. 2010, 37:3023-3028.
57. Park H.-J., et al. Identification of phosphorylation sites of TOPORS and a role for serine 98 in the regulation of ubiquitin but not SUMO E3 ligase activity. Biochemistry 2008, 47:13887-13896.
58. Hammer E., et al. The E3 ligase Topors induces the accumulation of polysumoylated forms of DNA topoisomerase I in vitro and in vivo. FEBS Lett. 2007, 581:5418-5424.
59. Pungaliya P., et al. TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying proteins. J. Proteome Res. 2007, 6:3918-3923.
60. Rasheed Z.A., et al. The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies. Exp. Cell Res. 2002, 277:152-160.
61. Renner F., et al. SUMOylation-dependent localization of IKKe{open} in PML nuclear bodies is essential for protection against DNA-damage-triggered cell death. Mol. Cell 2010, 37:503-515.
62. Weger S., et al. The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification: characterization of domains necessary for subcellular localization and sumolation. Exp. Cell Res. 2003, 290:13-27.
63. Doyle J.M., et al. MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. Mol. Cell 2010, 39:963-974.
64. Stephan A.K., et al. The Nse2/Mms21 SUMO ligase of the Smc5/6 complex in the maintenance of genome stability. FEBS Lett. 2011, 585:2907-2913.
65. Mullen J.R., et al. Wss1 is a SUMO-dependent isopeptidase that interacts genetically with the Slx5-Slx8 SUMO-targeted ubiquitin ligase. Mol. Cell. Biol. 2010, 30:3737-3748.
66. Huang C., et al. SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation. EMBO J. 2009, 28:2748-2762.
67. Itahana Y., et al. Nucleocytoplasmic shuttling modulates activity and ubiquitination-dependent turnover of SUMO-specific protease 2. Mol. Cell. Biol. 2006, 26:4675-4689.
68. Pichler A., et al. SUMO modification of the ubiquitin-conjugating enzyme E2-25K. Nat. Struct. Mol. Biol. 2005, 12:264-269.
69. Knipscheer P., et al. Ubc9 sumoylation regulates SUMO target discrimination. Mol. Cell 2008, 31:371-382.
70. Meulmeester E., et al. Mechanism and consequences for paralog-specific sumoylation of ubiquitin-specific protease 25. Mol. Cell 2008, 30:610-619.
71. Denuc A., et al. The UBA-UIM domains of the USP25 regulate the enzyme ubiquitination state and modulate substrate recognition. PLoS ONE 2009, 4:e5571.
72. Bernardi R., Pandolfi P.P. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 2007, 8:1006-1016.
73. Nisole S., et al. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 2005, 3:799-808.
74. Chu Y., Yang X. SUMO E3 ligase activity of TRIM proteins. Oncogene 2011, 30:1108-1116.
75. Weidtkamp-Peters S., et al. Dynamics of component exchange at PML nuclear bodies. J. Cell. Sci. 2008, 121:2731-2743.
76. Tavalai N., Stamminger T. New insights into the role of the subnuclear structure ND10 for viral infection. Biochim. Biophys. Acta 2008, 1783:2207-2221.
77. Lang M., et al. Three-dimensional organization of promyelocytic leukemia nuclear bodies. J. Cell Sci. 2010, 123:392-400.
78. Negorev D., Maul G.G. Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene 2001, 20:7234-7242.
79. Wang L., et al. Disruption of PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required for varicella-zoster virus pathogenesis in skin. PLoS Pathog. 2011, 7:e1002157.
80. Lilley C.E., et al. The intrinsic antiviral defense to incoming HSV-1 genomes includes specific DNA repair proteins and is counteracted by the viral protein ICP0. PLoS Pathog. 2011, 7:e1002084.
81. Wang Z.Y., Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 2008, 111:2505-2515.
82. Geoffroy M.C., et al. Arsenic-induced, SUMO-dependent recruitment of RNF4 into PML nuclear bodies. Mol. Biol. Cell 2010, 21:4227-4239.
83. Stehmeier P., Muller S. Phospho-regulated SUMO interaction modules connect the SUMO system to CK2 signaling. Mol. Cell 2009, 33:400-409.
84. Zhang X.W., et al. Arsenic trioxide controls the fate of the PML-RARα oncoprotein by directly binding PML. Science 2010, 328:240-243.
85. Jeanne M., et al. PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3. Cancer Cell 2010, 18:88-98.